sp-2577
Showing 1 - 1 of 1
SCCOHT, Ovarian Clear Cell Tumor, Ovarian Endometrioid Adenocarcinoma Trial in Scottsdale (SP-2577, Pembrolizumab)
Withdrawn
- SCCOHT
- +3 more
- SP-2577
- Pembrolizumab
-
Scottsdale, ArizonaHonorHealth Research Institute
Feb 11, 2022